Response by disease category, salvage number, and duration of first complete response
. | No. treated . | No. (%) . | . | . | ||
|---|---|---|---|---|---|---|
| Disease . | . | CR . | CRp/PR . | Overall . | ||
| AML | ||||||
| First salvage | ||||||
| CRD1, 12 mo or longer | 11 | 2 (18) | 0 | 2 (18) | ||
| CRD1, less than 12 mo | 8 | 6 (75) | 1 (13) | 7 (87) | ||
| Second or subsequent salvage | ||||||
| CRD1, 12 mo or longer | 4 | 2 (50) | 1 (25) | 3 (75) | ||
| CRD1, less than 12 mo | 8 | 3 (38) | 2 (25) | 5 (63) | ||
| MDS | ||||||
| First salvage | 6 | 2 (33) | 1 (17) | 3 (50) | ||
| Second or subsequent salvage | 2 | 0 (0) | 1 (50) | 1 (50) | ||
| CML, blastic phase | ||||||
| First salvage | 7 | 3 (43) | 1 (14) | 4 (57) | ||
| Second or subsequent salvage | 4 | 1 (25) | 1/1 (50) | 3 (75) | ||
| ALL | 12 | 1 (8) | 1 (8) | 2 (17) | ||
. | No. treated . | No. (%) . | . | . | ||
|---|---|---|---|---|---|---|
| Disease . | . | CR . | CRp/PR . | Overall . | ||
| AML | ||||||
| First salvage | ||||||
| CRD1, 12 mo or longer | 11 | 2 (18) | 0 | 2 (18) | ||
| CRD1, less than 12 mo | 8 | 6 (75) | 1 (13) | 7 (87) | ||
| Second or subsequent salvage | ||||||
| CRD1, 12 mo or longer | 4 | 2 (50) | 1 (25) | 3 (75) | ||
| CRD1, less than 12 mo | 8 | 3 (38) | 2 (25) | 5 (63) | ||
| MDS | ||||||
| First salvage | 6 | 2 (33) | 1 (17) | 3 (50) | ||
| Second or subsequent salvage | 2 | 0 (0) | 1 (50) | 1 (50) | ||
| CML, blastic phase | ||||||
| First salvage | 7 | 3 (43) | 1 (14) | 4 (57) | ||
| Second or subsequent salvage | 4 | 1 (25) | 1/1 (50) | 3 (75) | ||
| ALL | 12 | 1 (8) | 1 (8) | 2 (17) | ||
CRD1 indicates duration of first complete response; CR, complete response; CR-p, complete response without platelet recovery; and PR, partial response. Other abbreviations are explained in Table 1.